NASDAQ:PATH Investor Alert: Investigation of Acquisition of NuPathe Inc
An investigation on behalf of investors, who currently hold shares of NuPathe Inc (NASDAQ:PATH) shares, was announced concerning whether the takeover of NuPathe Inc by
Endo Health Solutions for $3.15 per share is unfair to NASDAQ:PATH stockholders.
View full press release